31 Mar 2023
Assets29.75
Total Income36.42
EBITDA3.28
Profit After Tax1.88
NET Worth1.01
Reserves and Surplus0.51
Total Borrowing16.19
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue19.51₹ Cr · -60.7% vs prior year
EBITDA4.24₹ Cr · -55.6% vs prior year
PAT2.87₹ Cr · -53.0% vs prior year
Assets56.29₹ Cr · +32.4% vs prior year
Net Worth19.10₹ Cr · +17.7% vs prior year
Borrowing15.32₹ Cr · -1.9% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2024
Assets33.88
Total Income35.87
EBITDA8.39
Profit After Tax4.87
NET Worth5.87
Reserves and Surplus5.37
Total Borrowing17.09
31 Mar 2025
Assets42.53
Total Income49.65
EBITDA9.54
Profit After Tax6.11
NET Worth16.23
Reserves and Surplus10.29
Total Borrowing15.62
31 Jul 2025
Assets56.29
Total Income19.51
EBITDA4.24
Profit After Tax2.87
NET Worth19.10
Reserves and Surplus13.16
Total Borrowing15.32
IPO UPDATE ALERTS
Register for IPO Updates →Track Curis Lifesciences without missing an update
Register for subscription, GMP, allotment and listing notifications.